Inventor · disambiguated record
Patrick Garidel
Also filed as: GARIDEL PATRICK
16 granted patents·20 pending applications·134 citations·filing 2004–2023
93Inventor score
Files withBOEHRINGER INGELHEIM INT7BOEHRINGER INGELHEIM PHARMA7PROTHENA BIOSCIENCES LTD6BASSARAB STEFAN5SCHULTZ-FADEMRECHT TORSTEN3
Top patents by PatentIndex Score
36 records- 0192US7723306B2Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparationBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted May 25, 2010·20 cites·45 claims
- 0292US7611709B21,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivativesBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted Nov 3, 2009·22 cites·43 claims
- 0385US10513555B2Antibody formulations and methodsPROTHENA BIOSCIENCES LTD·Filed 2014·Granted Dec 24, 2019·7 cites·23 claims
- 0483US11897964B2Anti-PSGL-1 antibodies and uses thereofALTRUBIO INC·Filed 2021·Granted Feb 13, 2024·1 cites·5 claims
- 0581US8096971B2Dual chamber container for lyophilization, process for the filling up and use thereofBASSARAB STEFAN·Filed 2006·Granted Jan 17, 2012·30 cites·18 claims
- 0680US11078265B2Anti-IL-23 antibodiesBOEHRINGER INGELHEIM INT·Filed 2013·Granted Aug 3, 2021·6 cites·32 claims
- 0780US7727962B2Powder comprising new compositions of oligosaccharides and methods for their preparationBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted Jun 1, 2010·2 cites·45 claims
- 0878US9089529B2Antibody formulations and methodsONCLAVE THERAPEUTICS LTD·Filed 2012·Granted Jul 28, 2015·7 cites·9 claims
- 0977US2024124604A1Anti-psgl-1 antibodies and uses thereofALTRUBIO INC·Filed 2023·Application pending·0 cites
- 1076US8002734B2Dual chamber container and process for its filling upBOEHRINGER INGELHEIM INT·Filed 2006·Granted Aug 23, 2011·25 cites·9 claims
- 1175US11572385B2Process for the preparation of concentrated liquid formulations containing biomoleculesBOEHRINGER INGELHEIM INT·Filed 2017·Granted Feb 7, 2023·2 cites·27 claims
- 1275US9884020B2Antibody formulations and methods for treating AL amyloidosisPROTHENA THERAPEUTICS LTD·Filed 2016·Granted Feb 6, 2018·3 cites·23 claims
- 1373US9753021B2Method for the evaluation of the colloidal stability of liquid biopolymer solutionsBOEHRINGER INGELHEIM INT·Filed 2013·Granted Sep 5, 2017·2 cites·16 claims
- 1469US8226982B2Inhalable powders comprising protein, phenylalanine, and other protein stabilizersSCHULTZ-FADEMRECHT TORSTEN·Filed 2007·Granted Jul 24, 2012·4 cites·39 claims
- 1568US7916289B2Apparatus for quantifying shear stress on a formulation comprising biomoleculesBOEHRINGER INGELHEIM INT·Filed 2008·Granted Mar 29, 2011·3 cites·13 claims
- 1666US2021077407A1Antibody Formulations and MethodsPROTHENA BIOSCIENCES LTD·Filed 2020·Application pending·0 cites
- 1761US10517830B2Antibody formulations and methodsPROTHENA BIOSCIENCES LTD·Filed 2018·Granted Dec 31, 2019·0 cites·9 claims
- 1861US2022213190A1Anti-cd19 antibody formulationsMORPHOSYS AG·Filed 2022·Application pending·0 cites
- 1959US2020140534A1Antibody formulations and methodsPROTHENA BIOSCIENCES LTD·Filed 2019·Application pending·0 cites
- 2057US2024393245A1Quantification method of polysorbate in aqueous formulationsBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 2156US2021317201A1Anti-il-23 antibodiesBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 2254US2005191246A1Powders comprising low molecular dextran and methods of producing those powdersBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 2354US2013251708A1Anti-psgl-1 antibodies and uses thereofABGENOMICS COOPERATIEF UA·Filed 2013·Application pending·0 cites
- 2450US2013209449A9Anti-psgl-1 antibodies and uses thereofBASSARAB STEFAN·Filed 2012·Application pending·0 cites
- 2550US2005064026A1Method for preparing homogenous liposomes and lipoplexesBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 2648US11352423B2Anti-CD19 antibody formulationsMORPHOSYS AG·Filed 2017·Granted Jun 7, 2022·0 cites·12 claims
- 2747US2009182301A1Dual chamber container without by-passBASSARAB STEFAN·Filed 2009·Application pending·0 cites
- 2847US2008071064A1TemperingSCHULTZ-FADEMRECHT TORSTEN·Filed 2007·Application pending·0 cites
- 2945US2007060875A1Dual chamber container without by-pass in the cylindrical bodyBASSARAB STEFAN·Filed 2006·Application pending·0 cites
- 3044US2007298116A1Amorphous, spray-dried powders having a reduced moisture content and a high long term stabilityBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 3144US2015344555A1Antibody formulations and methodsPROTHENA THERAPEUTICS LTD·Filed 2015·Application pending·0 cites
- 3243US2010143331A1Method for mixing powdersBOEHRINGER INGELHEIM PHARMA·Filed 2007·Application pending·0 cites
- 3343US2007060876A1Dual chamber container without by-passBASSARAB STEFAN·Filed 2006·Application pending·0 cites
- 3440US2017101470A1Use of Anti-MCAM Antibodies for Treatment or Prophylaxis of Giant Cell Arteritis, Polymyalgia Rheumatica or Takayasus ArteritisPROTHENA BIOSCIENCES LTD·Filed 2016·Application pending·0 cites
- 3536US2013199734A1Method for manufacturing protein solutions and their concentrationSCHULTZ-FADEMRECHT TORSTEN·Filed 2012·Application pending·0 cites
- 3634US2015259419A1Anti-MCAM Antibodies and Associated Methods of UsePROTHENA BIOSCIENCES LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Patrick Garidel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →